Guidelines for Corticosteroid use in Treatment of DMD
The guideline development subcommittee of the American Academy of Neurology has provided an update to the 2005 treatment guidelines for use of corticosteroids (CS) in Duchenne muscular dystrophy (DMD).
Egile nagusia: | Vamshi K. Rao |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Pediatric Neurology Briefs Publishers
2016-07-01
|
Saila: | Pediatric Neurology Briefs |
Gaiak: | |
Sarrera elektronikoa: | https://www.pediatricneurologybriefs.com/articles/1693 |
Antzeko izenburuak
-
Outcome of Long-Term Corticosteroid Treatment in Duchenne Muscular Dystrophy
nork: J Gordon Millichap
Argitaratua: (2007-06-01) -
Analysis of DMD translocations
nork: Cockburn, D, et al.
Argitaratua: (1991) -
Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry
nork: Leslie Cowen, et al.
Argitaratua: (2019-05-01) -
Interpretation of "Chinese guidelines for diagnosis and treatment of pseudohypertrophy muscular dystrophy"
nork: Cheng ZHANG
Argitaratua: (2018-07-01) -
Clinical study of DMD gene point mutation causing Becker muscular dystrophy
nork: Ji-qing CAO, et al.
Argitaratua: (2015-06-01)